Use of 12×/month haemoglobin monitoring with a computer algorithm reduces haemoglobin variability

Nephrology Dialysis Transplantation

Volumn 25, Issue 8, 2010, Pages 2710-2714

  Ho, Warren R ^a   Germain, Michael J ^a   Garb, Jane ^a   Picard, Sue ^b   MacKie, Molly Kate ^b   Bartlett, Cherry ^c   Will, Eric J ^c  

^a BAYSTATE MEDICAL CENTER   (United States)

^b FMC Enfield CT   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

anaemia management; erythropoietin; haemodialysis

Indexed keywords

FERRIC GLUCONATE; FERRLICET; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; ANTIANEMIC AGENT;

AGED; ALGORITHM; ANEMIA; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; MALE; OBSERVATIONAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; UNITED KINGDOM; BLOOD; CHRONIC DISEASE; COMPUTER ASSISTED THERAPY; DOSE RESPONSE; KIDNEY DISEASE; LONGITUDINAL STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; MONITORING; RENAL REPLACEMENT THERAPY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANEMIA; CASE-CONTROL STUDIES; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; RENAL DIALYSIS; THERAPY, COMPUTER-ASSISTED;

EID: 77954799969     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq016     Document Type: Article

References (20)

1. Ebben JP et al. Hemoglobin level variability: associations with co-morbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 2006; 1: 1205-1210
2. Will E. Intention and outcome in guideline-based nephrological practice: a suitable space for 'clinical technology'. Nephrol Dial Transplant 2007; 22: 3110-3114
3. Will E. Targets and targeting. Am J Kidney Dis 2001; 38: 411-414
4. Gabutti L et al. Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness? BMC Nephrology 2006; 7: 1-11
5. Will EJ et al. Development and exploitation of a clinical decision support system for the management of renal anaemia. Nephrol Dial Transplant 2007; 22: iv31-iv36
6. Richardson D, Bartlett C, Will EJ. Intervention thresholds and ceilings can determine the haemoglobin outcome distribution in a haemodialy- sis population. Nephrol Dial Transplant 2000; 15: 2007-2013
7. Gaweda AE et al. Model predictive control of erythropoeitin administration in the anemia ofESRD. AmJKidneyDis 2007; 51: 71-79
8. Singh AK et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
9. Gifford SC et al. A detailed study of time-dependent changes in human red blood cells: from reticulocyte maturation to erythrocyte senescence. Br J Haematol 2006; 135: 395-404
10. Drueke TB et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
11. Leypoldt JK et al. Determination of circulating blood volume by continuously monitoring hematocrit during hemodialysis. J Am Soc Nephrol 1995; 6: 214-219
12. Steuer RR et al. A new optical technique for monitoring hematocrit and circulating blood volume: its application in renal dialysis. Dialysis & Transplantation 1993; 22: 260-265
13. Yang W et al. Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 2007; 18: 3164-3170
14. Dixon WJ. BMDP/Dynamic. Los Angeles: BMDP Statistical Software, 1993
15. Jennrich RI, Turner FB. Measurement of non-circular home range. J Theor Biol 1969; 22: 227-237
16. Akaike H. Information Theory and an Extension of the Maximum Likelihood Principle. In Second International Symposium on Information Theory and Control. Budapest: Akademia Kiado, 1973; 267-281
17. Wald A. Tests of statistical hypotheses concerning several parameters when the number of observations is large. Transactions of the American Mathematical Society 1943; 54: 426-482
18. Agarwal R, Davis JL, Smith L. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 98-104
19. Brookhart MA et al. The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol 2008; 19: 1389-1395
20. Ho W et al. Frequent Hemoglobin (Hgb) Monitoring (12x/month) Can Inform Clinical and Organizational Decision Making. Dallas, Texas: 2008; Presented at NKF Spring Clinical Meeting